Mr. Klain named Pfizer as one of the companies the team would meet with but didn’t specify the others. The other drugmakers furthest along in COVID-19 vaccine development include Moderna, AstraZeneca and Johnson & Johnson.
“We’re going to have meetings between our top scientific advisers and the officials of these drug companies,” Mr. Klain told CNBC.
He stressed the importance of planning for vaccine distribution, saying: “It’s great to have a vaccine, but vaccines don’t save lives. Vaccinations save lives. And that means you’ve got to get that vaccine into people’s arms all over this country. It’s a giant logistical project.”
Read the full article here.
More articles on pharmacy:
HHS partners with 19 pharmacy networks for COVID-19 vaccine allocation
COVID-19 vaccines likely to have mild but painful side effects, scientists say
AstraZeneca says its cancer drug didn’t help COVID-19 patients in clinical trials
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
